Objective: To investigate the effects of transabdominal amnioinfusion (TA) on the histology of amnion (A) and umbilical cord (UC).
Introduction
When premature rupture of membranes (PROM) occurs in the early second trimester and is associated with severe oligohydramnios, standard approaches have traditionally included termination of pregnancy or expectant management. However, alternative strategies have been explored for treatment and repair of membrane rupture, such as use of serial amnioinfusions, intracervical tissue sealants, gelatin sponge embolization and amniopatch. [1] [2] [3] Amnioinfusion is the only approach that has been evaluated by independent investigators in nonrandomized series and it has been shown to lead to higher perinatal survival rates and lower incidence of pulmonary hypoplasia compared with expectant management. [1] [2] [3] [4] [5] [6] A recent randomized study 7 confirmed a significant prolongation of pregnancy in cases managed with amnioinfusion.
However, the infusion of normal saline into the amniotic fluid is not fully a physiologic replacement of amniotic fluid, with its wealth of growth factors and nutritive components. It is thus conceivable that exposure of the membranes to normal saline could have some deleterious effects on the integrity or histologic features of the amnion and umbilical epithelia. Because the effects of amnioinfusion on placental histology have not been addressed so far, we have investigated whether amnioinfusion in women with second trimester PROM and severe oligohydramnios has an effect on the histopathologic integrity of the epithelial surfaces of the amniochorionic membranes and umbilical cord and the underlying connective tissue. Since acute inflammation and uteroplacental ischemia, two factors implicated in the causation of PROM, may also affect the integrity of the epithelial surfaces, in the analysis we have taken into account the presence and severity of these two processes at histology.
Methods
We have accessed a database of consecutive singleton pregnancies with preterm PROM at <25.0 weeks lasting >4 days admitted at our institution between January 1998 and December 2004. Diagnosis of rupture of the membranes was made by observation of persistent vaginal pooling on sterile speculum examination and serial ultrasonographic observations. Gestational age (GA) was established by menstrual history and confirmed by ultrasonographic examination before 20 weeks.
Included in the present study were those with (1) oligohydramnios, defined as deepest pocket of amniotic fluid p2 cm and persisting for 4 days or longer, (2) no major fetal anomalies and (3) placental slides available for histopathological examination.
All patients were given hospital bed rest during the first week and received an initial 7-day course of antibiotic prophylaxis (sulbactam-ampicillin 3 g every 8 h or amoxicillin-clavulanic acid 2 g every 8 h i.v.). Digital examination was avoided until active labor. After the initial 7-day hospital stay, the patient was discharged home on bed rest if GA was <25 weeks; vaginal cultures were obtained every 2 weeks, and positive results for potentially pathogenic bacteria were treated. After 25 weeks' gestation, women were admitted to the hospital until delivery and they received at least one course of corticosteroid therapy (betamethasone 12 mg i.m. daily Â two doses). In the presence of preterm labor, tocolytic treatment (i.v. ritodrine) was administrated in the absence of clinical signs of chorioamnionitis or abruptio placentae. Fetal heart rate was monitored daily, and biophysical profile was performed twice a week. Amniotic fluid volume was assessed sonographically weekly on the outpatients, and every other day from admission until delivery.
Consenting women with persistent (>4 days) oligohydramnios (maximum cord-free pocket of amniotic fluid <2 cm) were offered serial amnioinfusions. Under sonographic guidance a 20-gauge needle was inserted transabdominally into the amniotic cavity. Transplacental passage was avoided whenever possible. We targeted either a small pocket of residual fluid or loops of cord between the fetal limbs, using color flow mapping to avoid puncturing the umbilical cord. The correct positioning of the needle was checked either by aspiration of a little amount of amniotic fluid or by ultrasonographic visualization of a free dispersion of normal saline solution within the amniotic cavity. The volume infused of normal saline solution was aimed at restoring a normal amount of amniotic fluid; we noted that infusion of 10 ml per week of GA was usually sufficient for this purpose. In no case did the procedure last longer than 15 min. If oligohydramnios recurred and persisted for >4 days, the procedure was repeated. Amnioinfusion was deemed successful if the mean deepest pocket of fluid during the latency period was >2 cm.
Delivery was expedited in the presence of clinical chorioamnionitis; fetal tachycardia with diminished variability, recurrent late or severe variable decelerations, or a biophysical profile score <6; abruptio placentae; or GA >34 weeks.
Placental pathology sampling and examination were performed following a standard protocol. For each case, at least two samples of the following were obtained: extra-placental membranes near the point of rupture and near the placenta; chorionic plate including the whole wall, distant from the marginal edge; decidua basalis; and umbilical cord (5 cm from the chorionic plate and at the proximal fetal end). Additional tissue samples were obtained if indicated by the presence of gross lesions. The slides (hematoxylin and eosin staining) were reviewed by an independent pathologist (CMS) who was blinded to the clinical data except GA at delivery and knowledge that in all cases amnioinfusion had been offered for persistent oligohydramnios. The histopathologic slides were reviewed with particular attention to epithelial integrity of the amnion and umbilical cord and underlying connective tissues. In the amnion, we recorded epithelial integrity, number and integrity of polymorphonuclear leukocytes (PMNs), cellularity and necrosis of connective tissue. In the umbilical cord, we analyzed epithelial or Wharton's jelly necrosis, PMN number, distance and integrity in the cord vessels and in the Wharton's jelly. For the purpose of the analysis, epithelial integrity was graded in a semiquantitative scale from 1 to 4 based on the distribution of the nuclei, which normally are distributed at regular intervals reflecting the size of each epithelial cell. Scattered nuclear dropout with retained cytoplasm (considered a sign of cell death with loss of nuclear staining but undissolved cytoplasm) was graded 1. Grade 4 was complete loss of all epithelium on the amnion basement membrane, or a naked basement membrane without viable cells (with nuclei and cytoplasm), or dead 'ghost' cells (no nuclear staining but preserved cytoplasm/cell shape).
Chorionic and basal plate were evaluated in particular for evidence of acute inflammation or uteroplacental ischemia, the two principal pathologic processes that have been implicated in the causation of PROM and that may affect histologic features of amnion and umbilical cord. Histologic evidence of acute inflammation was established by the number of neutrophils, their integrity and the extent of tissue invasion in amnion, choriodecidua and chorionic plate. Evidence of placental damage related to uteroplacental vascular pathology included abnormalities of uteroplacental vessels, fibrinoid necrosis and atherosis, abruption, villous infarcts, terminal villous fibrosis, increased syncytiotrophoblast knotting, cytotrophoblast ('X-cell') proliferation and villous hypovascularity. For the purpose of the analysis, the two pathologic processes (acute inflammation and uteroplacental ischemia) were evaluated in a stochastic way (as present or absent) as well as in a semiquantitative way, by averaging the scores of acute inflammatory and uteroplacental ischemia lesions.
Statistical analysis
Histologic and clinical characteristics of women who underwent amnioinfusion were compared with those of women with similar severity of oligohydramnios who did not undergo the procedure, using one-way ANOVA and Fisher's exact test; a P<0.05 was considered significant. Linear regression analysis was used to assess the independent effect of amnioinfusion on epithelial integrity of amnion and umbilical cord after controlling for acute inflammation and uteroplacental vascular pathology in chorionic and basal plate, defined as above. Moreover, to assess whether persistence of infused normal saline had an effect on epithelial integrity, we selected cases with oligohydramnios undergoing serial amnioinfusions and we compared the histologic features between those that retained the infusate (maintaining an average pocket of amniotic fluid >2 cm during latency) and those that did not.
Results
From a cohort of 56 consecutive cases of PROM at <25.0 weeks with placental histology available, we excluded 12 cases because they never developed oligohydramnios. In the remaining 44 cases, which constituted the study population, the mean±s.d. of the deepest pocket of amniotic fluid was 1.4 ± 0.8 cm. Fifteen out of 44 women (34%) declined amnioinfusion and 29 (66%) consented, with a median of three procedures (range 1 to 7). Median GA at PROM was 18.7±3.2 weeks, and GA at delivery was 26.1±5.0 weeks, with a latency period of 50 ± 38 days. Table 1 displays the clinical characteristics of the study population in relation to whether amnioinfusion was performed or not. On average, women who consented to the procedure had lower GA at membrane rupture, but significantly longer latency period, resulting in similar GA at delivery as women who declined the procedure. Table 2 displays the histologic characteristics of amnion, umbilical cord, and underlying connective tissue in relation to amnioinfusion (Figures 1 and 2 ). Amnion histology was available in 39/44 cases (89%); amnioinfusion was not associated with any significant change in the histologic features analyzed, with the exception of lower grade of epithelial necrosis in the umbilical cord of those who underwent amnioinfusions.
Histologic evidence of acute placental inflammation was present in 22/29 or 76% of the cases in the amnioinfusion group vs 15/15 or 100% of the non-amnioinfused cases (P ¼ 0.07), with an average acute inflammation score of 0.5 ± 0.45 and 0.9 ± 1.3, respectively (P ¼ 0.025). Our study had adequate statistical power to detect a difference of 26% of acute placental inflammation between the two groups; in other words, 51 total women would be required for the observed difference to achieve statistical significance (b ¼ 0.20, a ¼ 0.05). Histologic evidence of uteroplacental ischemia was present in 16/29 or 54% of the cases in the former group vs 3/15 or 20% in the latter group (P ¼ 0.052), with an average score of 0.3 ± 0.7 and 0.06 ± 0.3, respectively (P ¼ 0.005).
Linear regression analysis demonstrated that amnioinfusion was not significantly associated with scores of epithelial integrity after taking into consideration GA at PROM, mean amniotic fluid pocket during latency, duration of latency interval, histologic evidence of acute inflammation or uteroplacental ischemia (P ¼ 0.76 and P ¼ 0.12, respectively). Table 3 displays the characteristics of the study population among women with oligohydramnios who underwent serial amnioinfusions, in relation to whether the infusate was retained (maintaining an average pocket of amniotic fluid >2 cm during latency) or not. Retained fluid was associated with longer latency, greater GA at delivery, birth weight and survival. Table 4 shows the association between retained fluid and histologic features of amnion, cord and underlying connective tissues. Retention of the infused solution did not affect epithelial integrity, but it resulted in lower connective tissue necrosis and lower PMN integrity. The association between retained infusate and PMN integrity (P ¼ 0.8) or connective tissue necrosis (P ¼ 0.26) lost significance after controlling for latency period, histologic evidence of acute inflammation and uteroplacental ischemia.
Comment
We have found that amnioinfusion does not exert an adverse effect on the histopatologic features of the structures in contact with the amniotic cavity. In particular, epithelial integrity of amnion and umbilical cord, which may be more sensitive to changes in the composition of the fluid in the amniotic cavity, was not significantly different between cases that did or did not undergo amnionfusion after taking into consideration potential confounders. Moreover, we have observed a lack of effect of prolonged retention of the infused solution on epithelial integrity. Although the degree of confidence of our findings is tempered by the limited statistical power due to the inevitably small number of cases, the findings provide reassuring evidence that amnioinfusion per se, or prolonged exposure of the epithelium of the amnion to the infused solution (normal saline), does not damage epithelial cells.
Our study was underpowered to show a significant difference in rates of acute placental inflammation between the two groups. Moreover, the observed 0.4 point difference in placental acute inflammatory score between the two groups, although statistically significant, is probably clinically negligible given that the score ranges from 0 to 4. Although a difference was present in uteroplacental ischemia between the group undergoing amnioinfusion and the one that did not, the interpretation is hampered by GA at delivery, an important confounder that was significantly different between the two groups.
We were unable to provide insights into the mechanisms and processes responsible for rapid loss of infused solution leading to failure of serial amnioinfusions to maintain an adequate pocket of amniotic fluid pocket during latency. Intrauterine inflammation has been invoked to play a causal role in the failure of retention of the amnioinfused solution, as it may alter the dynamics of amniotic fluid production and reabsorption by the amnion, 8 thus reducing the probability of success of the procedure. Moreover, intrauterine infection may cause an increase in the resting tone of the myometrium, leading to an accelerated loss of the infused solution. Alternatively, characteristics of membrane rupture (for example, size or location of the defect in relation to the internal cervical os) may be responsible for a more prompt loss of the infused solution. 9 We confirm previous reports that amnioinfusion is associated with prolonged latency period and thus with improved perinatal outcome. In light of the negligible effects of amnioinfusion on histologic placental characteristics, the procedure should be considered for cases of extremely preterm PROM with severe oligohydramnios. Our study was limited by its non-randomized design. Multicenter prospective randomized trials are needed to confirm the results of the cohort series published so far.
